1. Home
  2. MGLD vs ICCM Comparison

MGLD vs ICCM Comparison

Compare MGLD & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MGLD

The Marygold Companies Inc.

N/A

Current Price

$1.13

Market Cap

49.5M

Sector

Finance

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.23

Market Cap

41.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGLD
ICCM
Founded
1996
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.5M
41.4M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
MGLD
ICCM
Price
$1.13
$0.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
5.9K
526.4K
Earning Date
05-08-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,876,734.00
N/A
Revenue This Year
N/A
$139.51
Revenue Next Year
N/A
$75.66
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$0.22
52 Week High
$1.38
$1.40

Technical Indicators

Market Signals
Indicator
MGLD
ICCM
Relative Strength Index (RSI) 50.75 28.02
Support Level $0.92 N/A
Resistance Level $1.32 $0.74
Average True Range (ATR) 0.08 0.03
MACD 0.00 0.00
Stochastic Oscillator 42.86 2.95

Price Performance

Historical Comparison
MGLD
ICCM

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: